Vannair (budesonide with eformoterol fumarate) 200/6: Supply issue
Supply of Vannair inhalers is once again available.
28 October 2026 | Stock arrived
A shipment has arrived and is available to order from the supplier.
Affected product
AstraZeneca, the supplier of Vannair, had limited stock of the following product.
Budesonide with eformoterol
- Brand: Vannair
- Presentation: Aerosol inhaler
- Strength: Budesonide 200 mcg with eformoterol fumarate 6 mcg
- Pharmacode: 2288974
- Subsidy: $21.40
- Measure / Qty: per 120 dose
Schedule listings for budesonide with eformoterol(external link)
Stock of the 100/6 presentation has been constrained, but a shipment has arrived and stock is available again.
Resolved late October
A shipment of the 100/6 strength arrived mid-October, this has been released to the market and we no longer expect anyone to be affected by this this supply constraint.
A shipment of the 200/6 strength has arrived and is available to order from the supplier again.
Both Pharmac and the supplier were monitoring the issue closely.
Pharmac will send out further communications as soon as possible, if we expect people will be affected.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)